Literature DB >> 12522754

A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level.

Patty W Wright1, Craig J Hoesley, Kathleen E Squires, Angela Croom-Rivers, Heidi L Weiss, John W Gnann.   

Abstract

A cohort of 217 human immunodeficiency virus type 1 (HIV-1)-seropositive women was observed prospectively from 1996 through 2000 to determine the frequency of genital herpes simplex virus type 2 (HSV-2) disease (symptomatic and asymptomatic) and to correlate those findings with HIV-1-related immunosuppression (absolute CD4 cell counts and plasma HIV-1 RNA levels). Participants underwent twice-yearly pelvic examinations, including cultures of cervicovaginal specimens and swab specimens from genital lesions, if lesions were present. Of the participants, 72 (33%) had genital HSV-2 infection diagnosed on the basis of either history alone (23 [32%]) or positive culture results (49 [68%]). The 72 women who had genital herpes diagnosed completed 242 total visits. Of these visits, positive HSV-2 culture results were noted at 80 (33%); at 23 (29%) of the 80 visits at which there were HSV-2-positive cultures, culture results were not associated with a clinically apparent genital lesion. Positive HSV-2 culture results occurred more frequently for samples obtained from patients with higher plasma HIV-1 RNA levels (P=.019) and lower CD4 cell counts (P<.001).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522754     DOI: 10.1086/345440

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Diagnostics for herpes simplex virus: is PCR the new gold standard?

Authors:  Lara B Strick; Anna Wald
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

2.  HIV prevention counseling intervention delivered during routine clinical care reduces HIV risk behavior in HIV-infected South Africans receiving antiretroviral therapy: the Izindlela Zokuphila/Options for Health randomized trial.

Authors:  Jeffrey D Fisher; Deborah H Cornman; Paul A Shuper; Sarah Christie; Sandy Pillay; Susan Macdonald; Ntombenhle Ngcobo; K Rivet Amico; Umesh Lalloo; Gerald Friedland; William A Fisher
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

3.  MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.

Authors:  Giulia Calenda; Guillermo Villegas; Patrick Barnable; Claudia Litterst; Keith Levendosky; Agegnehu Gettie; Michael L Cooney; James Blanchard; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

4.  Left out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV?

Authors:  Darrell H S Tan; Rupert Kaul; Sharon Walsmley
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

Review 5.  Herpes simplex virus type 2: epidemiology and management options in developing countries.

Authors:  G Paz-Bailey; M Ramaswamy; S J Hawkes; A M Geretti
Journal:  Sex Transm Infect       Date:  2006-11-10       Impact factor: 3.519

6.  Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.

Authors:  Aziz Alami Chentoufi; Xavier Dervillez; Pierre-Alain Rubbo; Tiffany Kuo; Xiuli Zhang; Nicolas Nagot; Edouard Tuaillon; Philippe Van De Perre; Anthony B Nesburn; Lbachir Benmohamed
Journal:  Curr Trends Immunol       Date:  2012

7.  Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2.

Authors:  Brian R Long; Ann E Erickson; Joan M Chapman; Jason D Barbour; Bien-Aimee N Vu; Emily L Ho; Lewis L Lanier; Mariana M Sauer; Karina I Carvalho; Douglas F Nixon; Esper G Kallas
Journal:  Immunology       Date:  2009-08-04       Impact factor: 7.397

8.  HIV-1 replication in HIV-infected individuals is significantly reduced when peripheral blood mononuclear cells are superinfected with HSV-1.

Authors:  Taneth Yamsuwan; Chintana Chirathaworn; Pokrath Hansasuta; Parvapan Bhattarakosol
Journal:  ScientificWorldJournal       Date:  2012-09-02

9.  Platinum(II) and palladium(II) complexes of pyridine-2-carbaldehyde thiosemicarbazone as alternative antiherpes simplex virus agents.

Authors:  D Kovala-Demertzi; T Varadinova; P Genova; P Souza; M A Demertzis
Journal:  Bioinorg Chem Appl       Date:  2007-02-14       Impact factor: 7.778

10.  The Prevalence, Antibiotic Resistance Pattern, and Associated Factors of Bacterial Vaginosis Among Women of the Reproductive Age Group from Felege Hiwot Referral Hospital, Ethiopia.

Authors:  Abebaw Bitew; Abeba Mengist; Habtamu Belew; Yibeltal Aschale; Alemayehu Reta
Journal:  Infect Drug Resist       Date:  2021-07-13       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.